A clinical study NERUNJI VER KUDINEER for KALLADAIPPU [Urolithiasis]

A Prospective Open Labelled Non Randomized Clinical Trial on herbal formulation of NERUNJI VER KUDINEER for the treatment of KALLADAIPPU[Urolithiasis]

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012710

Enrollment

Registered

2018-03-21

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- KALLADAIPPU

Interventions

Intervention1: NERUNJI VER KUDINEER: 100 ML BD FOR 30 DAYS Control Intervention1: NERUNJI VER KUDINEER: 100 ML BD FOR 30 DAYS

Eligibility

Inclusion criteria

Inclusion criteria: Age from 30 years to 60 years Patient With Renal Colicky pain Nausea Vomiting Haematuria Oliguria Pyuria Dysuria

Exclusion criteria

Exclusion criteria: Age Below 30 years and above 60 years Chronic Appendicitis Cholecystitis Pyelonephritis Recurrent UTI Diabetes Mellitus Metabolic disorders like Hyperthyroidism Hyperparathyroidism Pelvic Inflammatory Disease Chronic Renal Failure

Design outcomes

Primary

Measure	Time frame
Therapeutic efficacy of taial drug NERUNJI VER KUDINEER in KALLADAIPPUTimepoint: 30 days	—

Secondary

Measure	Time frame
Evaluation of Sidhha diagnostic parameters safety of trial drug Pharmacological and Biochemical analysis of trial drugTimepoint: 30 days	—

Countries

India

Contacts

Public ContactProf Dr A Manoharan MD

Govt Siddha Medical College And Hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026